C
Eli Lilly and Company LLY
$782.12 $28.443.77%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue 9.35B 9.50B 8.31B 6.96B 7.30B
Total Other Revenue -- -- -- -- --
Total Revenue 9.35B 9.50B 8.31B 6.96B 7.30B
Cost of Revenue 1.79B 1.86B 1.81B 1.63B 1.55B
Gross Profit 7.57B 7.64B 6.50B 5.33B 5.75B
SG&A Expenses 1.81B 1.69B 1.81B 1.63B 1.55B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 6.16B 5.96B 5.97B 5.25B 5.09B
Operating Income 3.19B 3.54B 2.34B 1.71B 2.21B
Income Before Tax 2.51B 427.20M 2.09B 1.53B 2.10B
Income Tax Expenses 319.10M 484.60M 325.70M 184.80M 158.70M
Earnings from Continuing Operations 2.19B -57.40M 1.76B 1.34B 1.94B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 2.19B -57.40M 1.76B 1.34B 1.94B
EBIT 3.19B 3.54B 2.34B 1.71B 2.21B
EBITDA 3.58B 3.95B 2.70B 2.08B 2.58B
EPS Basic 2.42 -0.06 1.96 1.49 2.14
Normalized Basic EPS 2.13 2.41 1.56 1.14 1.46
EPS Diluted 2.42 -0.06 1.95 1.49 2.14
Normalized Diluted EPS 2.13 2.41 1.56 1.14 1.46
Average Basic Shares Outstanding 903.98M 899.80M 899.70M 901.00M 904.73M
Average Diluted Shares Outstanding 903.98M 899.80M 902.70M 903.30M 904.73M
Dividend Per Share 1.13 1.13 1.13 1.13 0.98
Payout Ratio 46.49% -1,770.38% 57.72% 75.63% 45.64%
Weiss Ratings